Krystal Biotech Inc (KRYS)
153.14
-4.86
(-3.07%)
USD |
NASDAQ |
Apr 30, 16:00
153.14
0.00 (0.00%)
After-Hours: 19:59
Krystal Biotech Gross Profit Margin (Quarterly): 93.19% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 93.19% |
Date | Value |
---|---|
September 30, 2023 | 97.39% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
93.19%
Minimum
Dec 2023
97.39%
Maximum
Sep 2023
95.29%
Average
95.29%
Median
Gross Profit Margin (Quarterly) Benchmarks
Axsome Therapeutics Inc | 89.69% |
Alnylam Pharmaceuticals Inc | 80.47% |
Catalyst Pharmaceuticals Inc | 85.70% |
Ionis Pharmaceuticals Inc | 99.06% |
Madrigal Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Profit Margin (Quarterly) | 20.62% |
Operating Margin (Quarterly) | 7.45% |